


Respiro Diagnostics
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Respiro Diagnostics
Theo Issitt
Co-Founder
About Respiro Diagnostics
At Respiro Diagnostics, we're developing breath-based screening to detect lung cancer early, safely, and without hospital infrastructure. So patients and clinicians can act with confidence, not wait for symptoms. Because lung cancer often hides in plain sight. And when every day counts, early matters. We bring together cutting-edge science, real-world clinical insight, and technology built to shift the standard of care. Created with frontline needs in mind. Designed for everyday use. Built to move diagnostics forward. #EarlyDetection #BreathBasedDiagnostics #LungCancerScreening #HealthTech #Respiro
Respiro Diagnostics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Respiro Diagnostics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Respiro Diagnostics has never raised funding before.
Frequently asked questions
4.8
40,000 users



